GlassScriptPhysician profile
Nola Ernest
NPI 1134362817
$568.43
in general payments reported to CMS, 2019-2025
9 companies · $79.47 in 2025
The $79.47 reported for 2025 was less than what a typical Pediatrics provider received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $72.89 · 2020: $28.27 · 2021: $67.83 · 2022: $61.39 · 2023: $65.88 · 2024: $193 · 2025: $79.47.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $338.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $338.05 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ironshore Pharmaceuticals INC. | $110.09 | 2019-2024 | Jornay Pm |
| Corium, LLC | $105.45 | 2022-2024 | Azstarys |
| Merck Sharp & Dohme LLC | $103.73 | 2020-2025 | Gardasil 9, Vaxneuvance, Enflonsia |
| Pfizer INC. | $70.83 | 2019-2025 | |
| Genentech USA, INC. | $64.33 | 2024 | Xolair |
| Supernus Pharmaceuticals, INC. | $39.18 | 2021 | |
| Tris Pharma INC | $33.18 | 2019-2021 | |
| Neos Therapeutics, LP | $25.92 | 2019 | |
| Collegium Pharmaceutical, INC. | $15.72 | 2025 | Jornay Pm |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nola Ernest listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.